Access detailed search options for content from the Clinical Journal of Oncology Nursing & Oncology Nursing Forum below.
Quickly test your knowledge in this eight-question quiz that follows a patient from workup of metastatic non-small cell lung cancer (NSCLC) with an epidermal growth factor receptor (EGFR) Exon 20 insertion biomarker through multiple therapy lines.
Help your patients understand different therapy options so, together with the patient, there can be an informed treatment decision.
Learn more about the FDA Medwatch program and how nurses can recognize and report adverse events through the Recognize it; Report it online resource.
Use this checklist to ensure that you have completed the appropriate initial assessments and tests prior to starting your patient on a CDK4/6 inhibitor.
Better understand the mechanism of action when combining anti-hormonal therapy and a CDK4/6 inhibitor as a dual inhibitor to treat metastatic breast cancer.
Understand CDK4/6 inhibitor dosing and dose adjustments with this easy to interpret dosing guide.
Explains the mechanism of action or CDK4/6 inhibitor, a targeted therapy used in the treatment of HR+, HER2- metastatic breast cancer.
After your patient is prescribed a CDK4/6 inhibitor, use this video to ensure that you have completed the appropriate initial assessment and tests.